Comparative Pharmacokinetics of Δ9-Tetrahydrocannabinol in Adolescent and Adult Male and Female Rats.
Alexa Torrens, Pritam Roy, Lin Lin, Cindy Vu, Dakota Grimes, Victoria C Inshishian, Johanna S Montesinos, Faizy Ahmed, Stephen V Mahler, Marylin A Huestis, Aditi Das, Daniele Piomelli
Cannabis and Cannabinoid Research December 2022 DOI: 10.1089/can.2021.0205 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Comparative pharmacokinetic study in rats Peer reviewed |
|---|---|
| Population | Adolescent (33-day-old acute; 30–44-day-old subchronic) and young adult (70-day-old acute) male and female laboratory rats |
| Dose | 0.5 or 5 mg/kg (acute); 5 mg/kg (subchronic), intraperitoneal |
| Duration | Single acute administration or 2-week daily subchronic administration |
| Measures | isotope-dilution liquid chromatography/tandem mass spectrometry assay (plasma and brain THC, 11-OH-THC, 11-COOH-THC), body temperature via abdominally implanted microchips, liver microsome biotransformation assay |
| Topics | Cannabis |
| Keywords | Pharmacokinetics Δ9-tetrahydrocannabinol |
| Key points | The authors report multiple age and sex differences in THC distribution and metabolism in rats: adult plasma THC peaked twice as high as in adolescents, but adult brain-to-plasma ratios were 25–50% lower; 11-OH-THC was two- to sevenfold higher in females than males; and adolescent and female liver microsomes converted THC to 11-OH-THC twice as fast as adult male microsomes. Subchronic adolescent THC did not significantly alter the PK profile. |
Abstract
Introduction: Studies in rodent models have shown that adolescent exposure to Δ9-THC, the psychotropic constituent of cannabis, produces long-lasting alterations in brain function and behavior. However, our understanding of how age and sex might influence the distribution and metabolism of THC in laboratory rodents is still incomplete. In the present report, we provide a comparative analysis of the pharmacokinetic (PK) properties of THC in adolescent and adult rats of both sexes, and outline several dissimilarities across these groups.
Materials and Methods: A single (acute) or 2-week daily (subchronic) administration of THC (0.5 or 5 mg/kg, acute; 5 mg/kg, subchronic; intraperitoneal) was given to adolescent (33-day-old, acute; 30-44-day-old, subchronic) and young adult (70-day-old, acute only) male and female rats. THC and its first-pass metabolites-11-hydroxy-Δ9-THC (11-OH-THC) and 11-nor-9-carboxy-Δ9-THC (11-COOH-THC)-were quantified in plasma and brain tissue using a selective isotope-dilution liquid chromatography/tandem mass spectrometry assay. Changes in body temperature were measured using abdominally implanted microchips. Biotransformation of THC to its metabolites using freshly prepared liver microsomes was assessed.
Results: At the acute 5 mg/kg dose, maximal plasma concentrations of THC were twice as high in adult than in adolescent rats. Conversely, in adults, brain concentrations and brain-to-plasma ratios for THC were substantially lower (25-50%) than those measured in adolescents. Similarly, plasma and brain concentrations of THC metabolites were higher in adolescent male rats compared with adult males. Interestingly, plasma and brain concentrations of the psychoactive THC metabolite 11-OH-THC were twofold to sevenfold higher in female animals of both ages compared with males. Moreover, liver microsomes from adolescent males and adolescent and adult females converted THC to 11-OH-THC twice as fast as adult male microsomes. A dose-dependent hypothermic response to THC was observed in females with 0.5 and 5 mg/kg THC, whereas only the highest dose elicited a response in males. Finally, subchronic administration of THC during adolescence did not significantly affect the drug's PK profile.
Conclusions: The results reveal the existence of multiple age and sex differences in the distribution and metabolism of THC in rats, which might influence the pharmacological response to the drug.
Comparable studies
Other preclinical and animal studies on cannabis, most cited first.
Citations in the library
Cited by 6
- Influence of Carrier Oil, Sex, and Age on Pharmacokinetic and Acute Behavioral Effects of Vaporized Cannabis Extract in Mice. Cannabis and Cannabinoid Research December 1, 2025
- Adolescent THC impacts on mPFC dopamine-mediated cognitive processes in male and female rats. Psychopharmacology February 1, 2025
- Adolescent Exposure to a THC-Rich Cannabis Extract Produces Genotype-Dependent Effects on Cognition and Glial Morphology in Serine Racemase Mutant Mice. Journal of Neurochemistry September 2026
- Long-term effects of adolescent THC exposure on anxiety-like behavior and cognitive function in male rats Psychopharmacology April 23, 2026
- Comparative Pharmacokinetics of Δ9-Tetrahydrocannabinol in Adolescent and Adult Female Mice. Cannabis and Cannabinoid Research December 1, 2024
and 1 more in the library
Cites 3
- Pharmacokinetics and central accumulation of delta-9-tetrahydrocannabinol (THC) and its bioactive metabolites are influenced by route of administration and sex in rats. Scientific Reports December 14, 2021
- Pharmacokinetic and pharmacodynamic properties of aerosolized ("vaped") THC in adolescent male and female rats. Psychopharmacology December 2021
- The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. British Journal of Pharmacology January 2008